Researcher:
Turan, Janet Molzan

Profile Picture
ORCID

Job Title

Other

First Name

Janet Molzan

Last Name

Turan

Name

Name Variants

Turan, Janet Molzan

Email Address

Birth Date

Filters

20224

Advanced Search

Filter by

Settings

Researcher Of Publications: search.filters.isAuthorOfPublication.1c1cdf98-0115-4527-8b7e-4fb6f6ea4b4d

Search Results

Now showing 1 - 4 of 4
  • Placeholder
    PublicationMetadata only
    Adapting and pilot testing an HIV and intersectional stigma reducing intervention for Dominican Republic healthcare contexts: protocol for translational research
    (Elsevier, 2022) Budhwani, Henna; Paulino-Ramirez, Robert; Waters, John; Bond, Christyenne L.; Ruiz, Ingrid; Long, Dustin M.; Varas-Diaz, Nelson; Naar, Sylvie; Nyblade, Laura; N/A; Turan, Janet Molzan; Other; School of Medicine; N/A
    Background: This protocol details the adaptation and pilot testing of the Finding Respect and Ending Stigma around HIV (FRESH) intervention in Dominican Republic. FRESH is a healthcare setting stigma-reduction intervention designed to reduce stigmas affecting people living with HIV (PLHIV), focusing on HIV and intersectional stigmas experienced by sexual and gender minority (SGM) people living with HIV. After the successful adaptation of the FRESH intervention, it will be pilot-tested through the conduct of a pilot stepped wedge cluster randomized controlled trial. Methods: Three aims are included in this study; Aim 1 includes exploratory qualitative assessment, specifically the conduct four focus groups with men who have sex with men (MSM) living with HIV (n = 24-32) and in-depth interviews with transgender women living with HIV to explore their experiences with stigma in clinics (n = 9-12). In-depth interviews will also be held with HIV healthcare workers to elucidate their perceptions and behaviors towards their SGM clients (n = 9-12). In Aim 2, informed by Aim 1 data, we will use the sequential phases of the ADAPT-ITT framework to iteratively adapt the FRESH intervention for the Dominican Republic. In Aim 3, the adapted intervention will be pilot-tested via a cluster stepped wedge randomized controlled trial to assess feasibility and acceptability of the intervention and study protocols. Conclusions: If this pilot trial is successful, next steps will include testing the adapted intervention across Dominican Republic or in similar Spanish-speaking Caribbean nations in a larger trial to assess effectiveness in reducing stigma in clinical settings towards PLHIV.
  • Placeholder
    PublicationMetadata only
    Mhealth phone intervention to reduce maternal deaths and morbidity in cameroon: protocol for translational adaptation
    (Dove Medical Press, 2022) Bushwani, Henna; Enah, Comfort; Bond, Christyenne L.; Halle-Ekane, Gregory; Wallace, Eric; Szychowski, Jeff M.; Long, Dustin M.; Carlo, Waldemar A.; Tih, Pius M.; Tita, Alan T. N.; Turan, Janet Molzan; Other; School of Medicine; N/A
    Purpose: The purpose of this NIH-funded protocol is to adapt (Aim 1) and pilot test (Aim 2) an mHealth intervention to improve maternal and child health in Cameroon. We will adapt the 24/7 University of Alabama at Birmingham Medical Information Service via Telephone (MIST) provider support system to mMIST (mobile MIST) for peripheral providers who provide healthcare to pregnant and postpartum women and newborns in Cameroon. Methods: In Aim 1, we apply qualitative and participatory methods (in-depth interviews and focus groups with key stakeholders) to inform the adaptation of mMIST for use in Cameroon. We use the sequential phases of the ADAPT-ITT framework to iteratively adapt mMIST incorporating qualitative findings and tailoring for local contexts. In Aim 2, we test the adapted intervention for feasibility and acceptability in Ndop, Cameroon. Results: This study is ongoing at the time that this protocol is published. Conclusion: The adaptation, refinement, and pilot testing of mMIST will be used to inform a larger-scale stepped wedged cluster randomized controlled effectiveness trial. If successful, this mHealth intervention could be a powerful tool enabling providers in low-resource settings to deliver improved pregnancy care, thereby reducing maternal and fetal deaths.
  • Placeholder
    PublicationMetadata only
    Intimate partner violence and HIV treatment adherence in urban South Africa: mediating role of perinatal common mental disorders
    (Elsevier, 2022) Hatcher, Abigail M.; Stöckl, Heidi; Woollett, Nataly; García-Moreno, Claudía M.; Christofides, Nicola Joan; N/A; Turan, Janet Molzan; Other; School of Medicine; N/A
    Background: Antiretroviral therapy (ART) has potential to eliminate perinatal HIV infections, but adherence to ART in late pregnancy and postpartum is often suboptimal. Intimate partner violence (IPV) may influence non-adherence among perinatal women living with HIV (WWH), but few quantitative studies have examined this over time or explored mechanisms for this association. Methods: We used secondary data from a parent trial in Johannesburg comprising WWH from the control arm (n=63) and WWH ineligible for the trial (n=133). Trained nurse researchers administered questionnaires at first antenatal visit on past-year psychological, physical, and/or sexual IPV (WHO instrument), socio-demographics (age, food security, education), and perinatal common mental symptoms of depression (Hospital Anxiety and Depression Screener-d); anxiety (HADS-a); post-traumatic stress disorder (PTSD; Harvard Trauma Questionnaire). At endline visit 2-4 months postpartum, nurse researchers assessed self-reported ART adherence using a visual analog scale (with ≥95% considered “good”). We fitted structural equation models (SEM) in MPlus to explore direct and indirect effects of IPV on ART adherence. Results: Of 196 perinatal WWH, 53.1% reported IPV exposure at baseline. The majority of participants (85.7%) had good perinatal ART adherence. In adjusted models, IPV at baseline was associated with halved odds of good adherence (aOR=0.51, 95%CI=0.20-0.96). IPV was associated with higher adjusted odds of probable depression (aOR=4.64), anxiety (aOR=2.85), and PTSD (aOR=3.42). In SEM, IPV had a direct (standardized coef=-0.22) and indirect effect (coef=-0.05) on ART via common mental disorders. The total effect of IPV on perinatal adherence was of moderate size (coef= -0.27) and the model had good fit (CFI=0.972; TLI=0.969; RMSEA=0.045; SRMR=0.076). Conclusion: IPV was longitudinally associated with perinatal ART non-adherence in part due to its relationship with mental health symptomology. Addressing IPV within clinical care has potential to improve perinatal mental health, maternal HIV outcomes, and HIV-free infant survival.
  • Thumbnail Image
    PublicationOpen Access
    mHealth phone intervention to reduce maternal deaths and morbidity in cameroon: protocol for translational adaptation
    (Dove Medical Press, 2022) Budhwani, H.; Enah, C.; Bond, C.L.; Halle-Ekane, G.; Wallace, E.; Szychowski, J.M.; Long, D.M.; Carlo, W.A.; Tih P.M.; Tita, A.T.N.; Turan, Janet Molzan; Other; School of Medicine
    Purpose: the purpose of this NIH-funded protocol is to adapt (Aim 1) and pilot test (Aim 2) an mHealth intervention to improve maternal and child health in Cameroon. We will adapt the 24/7 University of Alabama at Birmingham Medical Information Service via Telephone (MIST) provider support system to mMIST (mobile MIST) for peripheral providers who provide healthcare to pregnant and postpartum women and newborns in Cameroon. Methods: in Aim 1, we apply qualitative and participatory methods (in-depth interviews and focus groups with key stakeholders) to inform the adaptation of mMIST for use in Cameroon. We use the sequential phases of the ADAPT-ITT framework to iteratively adapt mMIST incorporating qualitative findings and tailoring for local contexts. In Aim 2, we test the adapted intervention for feasibility and acceptability in Ndop, Cameroon. Results: this study is ongoing at the time that this protocol is published. Conclusion: the adaptation, refinement, and pilot testing of mMIST will be used to inform a larger-scale stepped wedged cluster randomized controlled effectiveness trial. If successful, this mHealth intervention could be a powerful tool enabling providers in low-resource settings to deliver improved pregnancy care, thereby reducing maternal and fetal deaths.